Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study on AK104 in Neoadjuvant Treatment of Cervical Cancer

NCT05227651 is registered in ClinicalTrials.gov with Akeso as lead sponsor.

NCT NCT05227651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05227651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study on AK104 in Neoadjuvant Treatment of Cervical Cancer
Lead sponsor
Akeso
Phase
Phase 2
Overall status
Completed
Start date
February 10, 2023
Completion date
September 27, 2024
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer